REITs invest in the majority of real estate property types, including offices, apartment buildings, warehouses, retail centers, medical facilities, data centers, cell towers and hotels.
Nareit’s REIT Directory provides a comprehensive list of REIT and publicly traded real estate companies that are members of Nareit. The directory can be sorted and filtered by sector, listing status, and stock performance.
CEM Benchmarking’s 2024 study also reveals allocations, returns, volatility, and risk-adjusted performance of 12 asset classes over 25-year period.
Multi-year partnership will allow McLaren to share its iconic heritage with fans, unlock value.
REITwise will take place March 24-26 in Hollywood, FL. This event is the leading educational conference for REITs, covering technical, regulatory, and operational updates.
For 65 years, Nareit has led the U.S. REIT industry by ensuring its members’ best interests are promoted by providing unparalleled advocacy, investor outreach, continuing education and networking.
Steadfast Apartment REIT president discusses acquisition conditions in target markets.
Investment-grade rating part of Physicians Realty Trust's long-term plan, says CEO John Thomas.
Luke Zubrod of Chatham Financial on the biggest risks and opportunities for REITs in the current derivatives marketplace.
New CEO taking "granular" look at portfolio.
David de la Rosa of Green Street Advisors on the development of Mexican REITs.
CEO Ted Rollins says company partnering with schools that provide best value.
Susan Wachter says REITs help diversify investment portfolios.
Tom Klaritch of HCP discusses the key elements of company's green platform.
Tyler Morse of MCR says foreign looking at hotels as safe havens.
COPT’s Roger Waesche Jr. discusses company’s approach to new development.
Ken Betts of Locke Lorde LLP says PNRLs looking to make liquidity events more effective.
CEO Bill Bayless says oversupply biggest concern for student housing sector.
NAREIT's Brad Case on a "tough month" for REIT investors.
Eastdil Secured’s David Lazarus discusses growth of PNLRs.